100 related articles for article (PubMed ID: 38788669)
1. Modifiable risk factors and inflammation-related proteins in polymyalgia rheumatica: genome-wide meta-analysis and Mendelian randomisation.
Zhao SS; Mackie SL; Larsson SC; Burgess S; Yuan S
Rheumatology (Oxford); 2024 May; ():. PubMed ID: 38788669
[TBL] [Abstract][Full Text] [Related]
2. Human leucocyte antigens and Japanese patients with polymyalgia rheumatica: the protective effect of
Nogi S; Oka S; Higuchi T; Furukawa H; Shimada K; Azuma T; Sugiyama T; Hirano F; Okamoto A; Fujimori M; Horai Y; Ihata A; Hashimoto A; Komiya A; Matsui T; Fukui N; Katayama M; Migita K; Tohma S
RMD Open; 2024 Jan; 10(1):. PubMed ID: 38253597
[TBL] [Abstract][Full Text] [Related]
3. A data-driven approach for studying the role of body mass in multiple diseases: a phenome-wide registry-based case-control study in the UK Biobank.
Hyppönen E; Mulugeta A; Zhou A; Santhanakrishnan VK
Lancet Digit Health; 2019 Jul; 1(3):e116-e126. PubMed ID: 33323262
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of HLA-DR polymorphism in polymyalgia rheumatica. Swiss Group for Research on HLA in Polymyalgia Rheumatica.
Guerne PA; Salvi M; Seitz M; Bruhlmann P; Rivier G; Frey D; Mermillod B; Vischer TL; Tiercy JM
J Rheumatol; 1997 Apr; 24(4):671-6. PubMed ID: 9101500
[TBL] [Abstract][Full Text] [Related]
5. HLA-DRB1 allele distribution in polymyalgia rheumatica and giant cell arteritis: influence on clinical subgroups and prognosis.
Martínez-Taboda VM; Bartolome MJ; Lopez-Hoyos M; Blanco R; Mata C; Calvo J; Corrales A; Rodriguez-Valverde V
Semin Arthritis Rheum; 2004 Aug; 34(1):454-64. PubMed ID: 15305244
[TBL] [Abstract][Full Text] [Related]
6. Distribution of HLA-DRB1 alleles of patients with polymyalgia rheumatica and giant cell arteritis in a Mediterranean population.
Combe B; Sany J; Le Quellec A; Clot J; Eliaou JF
J Rheumatol; 1998 Jan; 25(1):94-8. PubMed ID: 9458210
[TBL] [Abstract][Full Text] [Related]
7. Modifiable pathways for colorectal cancer: a mendelian randomisation analysis.
Cornish AJ; Law PJ; Timofeeva M; Palin K; Farrington SM; Palles C; Jenkins MA; Casey G; Brenner H; Chang-Claude J; Hoffmeister M; Kirac I; Maughan T; Brezina S; Gsur A; Cheadle JP; Aaltonen LA; Tomlinson I; Dunlop MG; Houlston RS
Lancet Gastroenterol Hepatol; 2020 Jan; 5(1):55-62. PubMed ID: 31668584
[TBL] [Abstract][Full Text] [Related]
8. Familial aggregation of polymyalgia rheumatica and giant cell arteritis: genetic and T cell repertoire analysis.
Bartolome MJ; Martínez-Taboda VM; Lopez-Hoyos M; Blanco R; Rodriguez-Valverde V
Clin Exp Rheumatol; 2001; 19(3):259-64. PubMed ID: 11407077
[TBL] [Abstract][Full Text] [Related]
9. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica.
Boiardi L; Casali B; Farnetti E; Pipitone N; Nicoli D; Cantini F; Macchioni P; Bajocchi G; Catanoso MG; Pulsatelli L; Consonni D; Salvarani C
J Rheumatol; 2006 Apr; 33(4):703-8. PubMed ID: 16583473
[TBL] [Abstract][Full Text] [Related]
10. Assessing the causal role of epigenetic clocks in the development of multiple cancers: a Mendelian randomization study.
Morales Berstein F; McCartney DL; Lu AT; Tsilidis KK; Bouras E; Haycock P; Burrows K; Phipps AI; Buchanan DD; Cheng I; ; Martin RM; Davey Smith G; Relton CL; Horvath S; Marioni RE; Richardson TG; Richmond RC
Elife; 2022 Mar; 11():. PubMed ID: 35346416
[TBL] [Abstract][Full Text] [Related]
11. Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial.
Devauchelle-Pensec V; Carvajal-Alegria G; Dernis E; Richez C; Truchetet ME; Wendling D; Toussirot E; Perdriger A; Gottenberg JE; Felten R; Fautrel BJ; Chiche L; Hilliquin P; Le Henaff C; Dervieux B; Direz G; Chary-Valckenaere I; Cornec D; Guellec D; Marhadour T; Nowak E; Saraux A
JAMA; 2022 Sep; 328(11):1053-1062. PubMed ID: 36125471
[TBL] [Abstract][Full Text] [Related]
12. Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association.
Dababneh A; Gonzalez-Gay MA; Garcia-Porrua C; Hajeer A; Thomson W; Ollier W
J Rheumatol; 1998 Nov; 25(11):2140-5. PubMed ID: 9818656
[TBL] [Abstract][Full Text] [Related]
13. Polymyalgia rheumatica and risk of coronary artery disease: a systematic review and meta-analysis of observational studies.
Ungprasert P; Koster MJ; Warrington KJ; Matteson EL
Rheumatol Int; 2017 Jan; 37(1):143-149. PubMed ID: 27577940
[TBL] [Abstract][Full Text] [Related]
14. HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis.
Weyand CM; Hunder NN; Hicok KC; Hunder GG; Goronzy JJ
Arthritis Rheum; 1994 Apr; 37(4):514-20. PubMed ID: 8147928
[TBL] [Abstract][Full Text] [Related]
15. DRB1 alleles in polymyalgia rheumatica and rheumatoid arthritis in southern France.
Reviron D; Foutrier C; Guis S; Mercier P; Roudier J
Eur J Immunogenet; 2001 Feb; 28(1):83-7. PubMed ID: 11251689
[TBL] [Abstract][Full Text] [Related]
16. Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms.
Mattey DL; Hajeer AH; Dababneh A; Thomson W; González-Gay MA; García-Porrúa C; Ollier WE
Arthritis Rheum; 2000 Aug; 43(8):1749-55. PubMed ID: 10943865
[TBL] [Abstract][Full Text] [Related]
17. Comorbidities in polymyalgia rheumatica: a systematic review.
Partington R; Helliwell T; Muller S; Abdul Sultan A; Mallen C
Arthritis Res Ther; 2018 Nov; 20(1):258. PubMed ID: 30458857
[TBL] [Abstract][Full Text] [Related]
18. Is cancer associated with polymyalgia rheumatica? A cohort study in the General Practice Research Database.
Muller S; Hider SL; Belcher J; Helliwell T; Mallen CD
Ann Rheum Dis; 2014 Oct; 73(10):1769-73. PubMed ID: 23842460
[TBL] [Abstract][Full Text] [Related]
19. IL-6 promoter polymorphism at position -174 modulates the phenotypic expression of polymyalgia rheumatica in biopsy-proven giant cell arteritis.
Gonzalez-Gay MA; Hajeer AH; Dababneh A; Garcia-Porrua C; Mattey DL; Amoli MM; Thomson W; Ollier WE
Clin Exp Rheumatol; 2002; 20(2):179-84. PubMed ID: 12051396
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the causal relationship between five modifiable factors and the risk of spinal stenosis: a multivariable Mendelian randomization analysis.
Wan B; Ma N; Lu W
PeerJ; 2023; 11():e15087. PubMed ID: 36967997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
